Idexx shares: Idexx earnings win easily

At the beginning of Tuesday IDEXX Laboratories (((IDXX) First-quarter sales were $ 7.78 million and adjusted earnings per share was $ 2.35. The Idexx strain was not yet active.


On average, analysts surveyed by FactSet expected Idexx to make $ 1.71 per share with sales of $ 738.4 million.

In the year-ago quarter, Idexx’s revenue per share was $ 1.29 and veterinary diagnostic player revenue was $ 626.3 million.

This year, Idexx saw EPS from $ 7.88 to $ 8.18 and revenue from $ 3.105 billion to $ 3.16 billion. Analysts demanded $ 7.57 in Idexx revenue and $ 3.1 billion in revenue per share.

In pre-market transactions Stock market todayAfter closing at 549.88 on Monday, Idexx shares were not yet traded. Idexx strain is formed Cup base with handle With Purchase points According to 561.62

Idexx Labs IBD long-term leader list..

Details to follow.

Follow Allison Gatlin on Twitter. @IBD_AGatlin..

You may like it too:

Vaxart shares plummet to widening losses as investors turn to Covid Pill

Lower Vaccine Repellent — What This Means For Covid Strain

Learn how to time the market with IBD’s ETF market strategy

Options Trading: How to start using options, how to manage risk

Get timely trading alerts on the IBD leaderboard

Idexx shares: Idexx earnings win easily

Source link Idexx shares: Idexx earnings win easily

Back to top button